References
- Valentino LA, Oza VM. Blood safety and the choice of anti-hemophilic factor concentrate. Pediatr Blood Cancer 2006; 47: 245–54. doi: 10.1002/pbc.20895.
- Zimmerman B, Valentino A. Haemophilia: in review. Pediatr Rev 2013; 34: 289–95. doi: 10.1542/pir.34-7-289.
- Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the management of haemophilia. Haemophilia 2013; 19: e1–e47. doi: 10.1111/j.1365-2516.2012.02909.x.
- Berntorp E, Shapiro AD. Modern haemophilia care. Lancet 2012; 379: 1447–56. doi: 10.1016/S0140-6736(11)61139-2.
- Center for Disease Control and Prevention. Haemophilia treatment centers. Available from https://www.cdc.gov/ncbddd/haemophilia/htc.html (accessed 1 May 2019).
- Partners in Bleeding Disorder Education. Available from www.partnersprn.org (accessed 1 May 2019).
- Health Resources & Services Administration. 340B Drug Pricing Program. Available from https://www.hrsa.gov/opa/index.html (accessed 9 September 2020).
- O'Hara J, Hughes D, Camp C, Burke T, Carroll L, Diego DG. The cost of severe haemophilia in Europe: the CHESS study. Orphanet J Rare Dis 2017; 12(1): 106. doi: 10.1186/s13023-017-0660-y. PMID: 28569181; PMCID: PMC5452407.
- Pedra G, Christoffersen P, Khair K, et al. The impact of factor infusion frequency on health-related quality of life in people with haemophilia. J Haem Pract 2020; 7(1): 102–109. doi: 10.17225/jhp00158.
- Santaella M, Bloomberg M, Anglade D. Home infusion teaching practices at federally funded haemophilia treatment centers in the United States of America. Res Pract Thromb Haemost 2017; 1(1): 81–89. doi:10.1002/rth2.12020.
- Nossair F, Thornburg CD. The role of patient and healthcare professionals in the area of new haemophilia treatments in developed and developing countries. Ther Adv Hematol 2018; 9: 239–49. doi: 10.1177/2040620718784830.
- Barry MJ, Edgman-Levitan S. Shared decision making – the pinnacle of patient-centered care. N Engl J Med 2012; 366: 780–1. doi: 10.1056/NEJMp1109283.
- Elwyn G, Laitner S, Coulter A, Walker E, Watson P, Thomson R. Implementing shared decision making in the NHS. BMJ 2010; 341: c5146. doi: 10.1136/bmj.c5146.
- Nurse Journal. What is a family nurse practitioner (FNP)? Available from https://nursejournal.org/family-practice/role-scope-of-practice-of-a-family-nurse-practitioner/ (accessed 27 November 2019).
- American Hospital Association. Fact Sheet: The 340B Drug Pricing Program. 2019. Available from https://www.aha.org/system/files/2019-01/fact-sheet-340b-0119.pdf (accessed 7 August 7 2020).
- Medicare Payment Advisory Commission. Overview of the 340B Drug Pricing Program. 2015. Available from http://www.medpac.gov/docs/default-source/reports/may-2015-report-to-the-congress-overview-of-the-340b-drug-pricing-program.pdf?sfvrsn=0 (accessed 7 August 7 2020).
- National Haemophilia Foundation (NHF). NHF Policy Statement Haemophilia Treatment Center Participation in the 340B Drug Discount Program. NHF, 2015. Available from https://www.haemophilia.org/sites/default/files/document/files/NHF-Position-Statement-Regarding-Haemophilia-Treatment-Center-Participation-in-the-340B-Drug-Discount-Program.pdf (accessed 7 August 7 2020).
- Polit DF, Beck CT. Nursing Research: Generating and Assessing Evidence for Nursing Practice. 9th edition. Philadelphia, PA: Lippincott, Williams and Wilkins; 2012.